Medicaid Fraud Settlement: Two Partnership Lessons for Physicians
Sep 26, 2013
A recent Medicaid fraud settlement in Texas holds two important lessons for physicians regarding business relationships.
anti-kickback statute
Courts Are Not Taking Anti-Kickback Violations Lightly
Aug 29, 2013
A pair of recent court decisions further highlights the need for physicians to comply with the Anti-Kickback Statute and the Sunshine Act.
OIG Opinion on Federal 'Carve Out' May Implicate ACOs
Aug 11, 2013
A recent decision by HHS' Office of the Inspector General raises some interesting issues with ACOs participating in the Medicare Shared Savings Program.
Physicians Cautioned to Scrutinize Their Carve-Out Arrangements
Jun 28, 2013
HHS' Office of Inspector General reiterates antipathy towards some physician arrangements that carve out federal referrals.
Physician-Owned Distributorships Raise Heightened Concern by OIG
Apr 26, 2013
The OIG deems PODs to be inherently suspect under the Anti-Kickback Statute, so physicians should take note.
Potential Pitfalls of Physicians Owning Compounding Pharmacies
Apr 21, 2013
Here are some legal and ethical issues to consider before you own and operate a compounding pharmacy at your medical practice.
Kickback and Self–referral Statutes Physicians May be Violating
Mar 18, 2013
Business practices generally accepted in other industries can be illegal in healthcare, so it is important to be sure you are in compliance.
Ancillary Medical Services: Stark Law and Ethical Issues
Mar 10, 2013
Physicians are being presented with chances to invest in ancillary services, but they need to be aware of all the legal issues involved to avoid potential pitfalls.
Key Areas of Federal Healthcare Fraud Investigations
Feb 19, 2013
Want to know what the government looks for in healthcare fraud investigations? Here's some conduct you may want to avoid at your medical practice.
The New Sunshine Act Regulations for Physicians
Feb 10, 2013
There will be a lot more data gathering and reporting of physician payments from pharma and others under the proposed Sunshine Act. Here's what you need to know.